Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-09-28

FDA Approved: NOREPINEPHRINE BITARTRATE — Supplemental Application (Meitheal Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for norepinephrine bitartrate from Meitheal Pharmaceuticals Inc. to market this generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Norepinephrine bitartrate (Norepinephrine bitartrate)

Snippet

SUPPL AP for NOREPINEPHRINE BITARTRATE (NOREPINEPHRINE BITARTRATE)